InMode

Expansion In Thailand And Argentina Will Boost Revenue Despite Risks

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

24 Sep 24

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-26.7%

3.1%

-26.7%

3.1%

You can edit this narrative until May 12 6:03 AM. Then, changes will post as Updates.

Author's Valuation

US$16.2512.3% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Fair value Decreased 21%

Shared on 23 Apr 25

Fair value Decreased 1.82%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Decreased 0.81%

AnalystConsensusTarget has decreased revenue growth from 3.9% to 3.4%.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 0.57%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 11 Mar 25

Fair value Increased 23%

AnalystConsensusTarget has increased revenue growth from 2.4% to 3.9%, decreased future PE multiple from 11.6x to 9.2x and increased discount rate from 7.4% to 8.8%.

AnalystConsensusTarget Fair Value

US$16.25

12.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.65%

Medical Equipment revenue growth rate

8.27%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

9.59%

Calculation

US$94.20m

Earnings '28

11.27x

PE Ratio '28

US$1.06b

Market Cap '28

US$1.06b

Market Cap '28

50.88m

No. shares '28

US$20.87

Share Price '28

US$20.87 Share Price '28

Discounted to 2025 @ 9.33% p.a.

US$15.97

Fair Value '25